Will Interchangeable Insulin Be More Affordable?

Will Interchangeable Insulin Be More Affordable in the US? Alicia Ault September 08, 2021
When the US Food and Drug Administration (FDA) approved Semglee, the first interchangeable biosimilar insulin, the agency pitched it as having the potential to be less costly than insulins currently on the market, but lack of transparency in pharmaceutical pricing has left analysts and advocates guessing whether it will indeed be a source of relief.

Read the source article at emedicinehealth.com
2021-09-08 16:00:00